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Abstract
Background: Mineral based preparations are widely used for centuries as antimicrobial agents. However, the
efficacy and the mode of action of mineral based preparations are uncertain due to the insufficient antimicrobial
studies. Arogyawardhana Vati (AV) and Manikya Rasa (MR) are such two Rasashastra herbo-minerallic drugs
commonly in India and other countries in South Asia. Despite of their well known traditional use of skin diseases,
reported antimicrobial and mineralogical studies are limited. Therefore, in this study antimicrobial activities of the
drugs and their organic, inorganic fractions were evaluated against Pseudomonas aeruginosa, Escherischia coli,
Staphylococcus aureus, Methecilline Resistance Staphylococcus aureus - MRSA and Candida albicans.
Methods: Antimicrobial activity of the drugs, their inorganic residues and organic extracts were determined using
four assay techniques viz agar well diffusion, modified well diffusion, Miles and Misra viable cell counting and broth
turbidity measurements. Mineralogical constituents of the drugs were determined using X-ray diffraction, while total
cation constituents and water soluble cation constituents were determined using inductively coupled plasma-mass
spectrometer and the atomic absorption spectrophotometer respectively. Thermogravimetric analysis was used to
determine the weight percentages of organic and inorganic fraction of the drugs. Particle sizes of the drugs were
determined using the particle size analyzer.
Results: AV and MR drugs showed antibacterial activity against both gram positive and gram negative bacterial
species when analyzed separately. Inorganic residues of the drugs and organic extracts showed activity at least
against two or more bacterial species tested. All tested components were inactive against C. albicans. Common
mineral constituents of drugs are cinnabar, biotite and Fe-rich phases. Drugs were rich in essential elements such as
Na, K, Ca, Mg and Fe and toxic elements such as Zn, Cu and As. However, the water soluble concentrations of the
toxic elements were below the detection limits. Both drugs have significantly higher percentages of organic
constituents and volatile minerals and particle sizes of drugs are in the nanometer range.
Conclusions: AV and MR Rasashastra preparations could provide alternatives to synthetic antibiotics against human
bacterial infections. Improved solubility and reduced particle sizes are influential physicochemical properties used to
enhance the antimicrobial efficacy of the drugs. Therefore, traditional knowledge on the use of antimicrobial
mineral sources could provide a novel path for the producing of effective antimicrobial drugs. However, further
chemical and toxicological studies are urgently needed for a greater understanding of their toxicity to humans.
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Background
Evolution of microbial resistance, potential health haz-
ards and side effects of exsisting synthetic antimicrobial
drugs has led to the investigation of novel antimicrobial
agents derived from traditional preparations. Researches
in modern medicine have proven that certain metals are
effective in antimicrobial functions that cannot be met
only by organic molecules [1, 2]. Therefore, mineral
based antimicrobial products have recently come into
the picture as a potential solution to the rising incidence
of drug resistance in microbes [3, 4].
Although some of the metal ions are essential for
cellular functions, the same metal ions are toxic to the
cells when they are in excess amounts [1]. Certain metal
ions bearing natural sources have antimicrobial activity
even at very low concentrations and said to have rela-
tively low toxic potential when taken orally [5], these
metallic sources have been used as anti microbial agents
since ancient times. Sulfides bearing minerals, metal
oxides and alumino silicates including biotite mica are
some of the minerals that have been used in traditional
preparations as metallic antimicrobial sources through-
out the world for centuries [6–8].
‘Rasashstra’ (Ancient science of alchemy) is the branch
of Ayurveda that deals with mineral based drug prepara-
tions. In most cases minerals are used as combinations
with plant parts, animal by products or any other
organic material. Although a few herbometallic trad-
itional preparations possessing antimicrobial activity
have been identified, mineral based antimicrobial
sources in Rasashastra medicine has long been used
without much understanding.
Arogyawardhana Vati (AV) and Manikya Rasa (MR)
drugs are commonly known herbometallic preparations
in the Rasashastra medicine, that are prepared by
mixing a number of plant parts and purified mineral
material [9–12]. AV and MR drugs are traditionally used
mainly for skin ailments. In addition, AV is also used to
improve appetite and digestion, bowel disorders and as a
tonic for heart, liver, uterus, kidneys, intestines [13–18],
while, MR is used for allergic conditions, dermatitis,
fever, anemia, hiccups and jaundice [13, 19–21].
Therefore, these herbo-metallic preparations could have
potential to substitute allopathic drugs for the treatment
of number of disorders including skin infections caused by
microorganism. Hence, the rationalization of specific indi-
cations in these products based on their antimicrobial,
mineralogical and chemical characteristics is important
and useful. Therefore, commercially available AV and MR
products were tested for their antimicrobial activities
against four bacterial species and one fungal species
that are associated with skin diseases, and/or commonly
considered as pathogens. Further, the present study was
undertaken to investigate the physical and chemical
properties of the mineralogical constituents responsible
for antibacterial activity.
Among the most common skin pathogens Pseudo-
monas aeruginosa has become known as one of the most
problematic gram-negative pathogens with its alarmingly
high antibiotic resistance rates [22]. Staphylococcus
aureus is another most common human pathogens that
leads to many types of infection. This bacterium is
responsible for local infections, such as wounds or post
operative infection and also for prosthetic infections. S.
aureus is also known to possess an increasing ability to
resist antibiotics such as penicillin, methicillin, tetracyc-
line, erythromycin and vancomycin [23]. Escherichia coli
are known to be multi resistant bacteria and present in
large numbers in the normal intestinal flora of humans,
generally causing no harm. However, a number of en-
teropathogenic strains can cause acute diarrhea, abdom-
inal cramps, nausea and headache. Others have been
associated with non-bloody diarrhea, vomiting and fever
in infants [22, 24]. Other than the bacterial infections,
oral candidiasis and cutaneous candidiasis are common
diseases found in the oral cavity and in the folds of the
skin caused by fungal infections. Oral candidal infection
may spread to the gastrointestinal tract, trachea, lungs,
liver and central nervous system opportunistically and
capable of causing septicemia, meningitis and endocar-
ditic. Cutaneous candidiasis is found in armpits, hands,
groins, buttocks, and under breasts. Among the Candida
species, Candida albicans isolated from oral cavity and
skin folds are generally responsible for fungal diseases
[2, 25, 26]. Thus, it is necessary and important to evalu-
ation and identify novel alternative herbo-metallic
antimicrobial agents for the above causative pathogens




“Arogyawardhana Vati” (AV) and “Manikya Rasa”
(MR), two Rasashastra preparations, were purchased
from, Kiriwatthuduwa Liweris Amarathunga company
Ltd, a reputed Sri Lankan Ayurvedic preparation
center.
Preparation of extracts
Fractionations of organic and inorganic components of
the AV and MR drugs were carried out using a sequen-
tial extraction (soxhelt extraction) procedure with hex-
ane (≥99.0 %), dichloromethane (99.6 %) and methanol
(≥99.8 %). Extraction period was 24 h for each solvent.
All chemicals and solvents used in the experiments were
analytical grade high purity solvents from Sigma-Aldrich
Company.
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Microbial strains and antimicrobial analysis
All crude extracts, their drugs and residues (inorganic)
were used to assess the antimicrobial activity using, agar
dilution method, well diffusion assay and a modified
version of the same (placing the drug or its components
directly on the agar surface), using Mullar Hinton Agar
(MHA). The crude extracts were dissolved separately in
diluted DMSO (1:7; DMSO: water). Each drug and their
components were tested (at 10,000 ppm concentration)
against Pseudomonas aeruginosa (ATCC-27853), Escher-
ischia coli (ATCC 25922), Staphylococcus aureus (ATCC
25923), Methecilline Resistance Staphylococcus aureus –
MRSA and Candida albicans (ATCC 90028), and incu-
bated at 37 °C for 24 h. Inocula of each microbial strain
were prepared by suspending 18 to 24 h old cultures in
NaCl (0.85 %). Turbidity of each inocular was adjusted
similar to 0.5 McFarland standards.
Inocula were flooded onto the surface of Petri plates
containing 25 ml of MHA. Wells of 3 mm diameter were
cut in the agar using a sterile cork borer. The bases of the
wells were sealed by adding a drop of molten agar into
each well. Aliquots (100 μl) of the extracts were added
into separate wells. Diluted DMSO was used as the nega-
tive control. After incubation overnight at 37 °C, the plates
were examined and the diameter of the zone of inhibition
was measured. A similar test was performed devoid of
wells, directly placing and 5 μl suspensions from each
extract on the MHA surface as the modified diffusion
method.
Inoculated Brain Heart Infusion (BHI) broth cultures
of turbidity similar to 0.5 McFarland standard of the
above mentioned microorganisms were mixed with the
AV and MR drugs (10,000 ppm) and the residues of the
drug (remaining solid after the sequential extraction
with hexane, dichloromethane and methanol) separately
and incubated at 37 °C for 18–24 h in a shaking water
bath. The antimicrobial activities of the above compo-
nents were quantitatively investigated using Miles and
Misra method for viability [27] as follows. After incuba-
tion 100 μl of the culture was serially diluted and plated
on MHA plates. The plates were incubated at 37 °C for
24 h. After incubation, colony forming units (cfu)
were recorded in respective dilutions of all the treated
samples.
The above incubated broth cultures, including the
blank samples devoid of drug or residue were centri-
fuged at 300 rpm for 1 min (sufficient for sediment of
the drug or its residue only) and the supernatant (pre-
sumably containing microbes) was separated out to test
the change in turbidity due to microbial growth by
means of absorbance with UV-Visible spectrophotom-
eter. All the experiments were replicated three times.
Antimicrobial assays were carried out at the Department
of Botany, Faculty of science and Department of
Microbiology, Faculty of Medicine, University of Perade-
niya, Sri Lanka.
Mineralogical analysis
Mineralogical compositions of samples were analyzed at
the Technical University, Darmstadt, Germany using
Siemens D-5000 X-ray Diffraction (XRD) instrument at
40 kV and 34 mA using CuKα radiation of 1.54° A wave-
length to determine the properties of crystalline phases
of the two drugs. To obtained more precise data with
high resolution, samples were analyzed in duplicates
with different scanning speeds (1 and 0.1°/min).
Thermogravimetric Analysis (TGA) was performed
using Scinco STA N-650 machine to determine the ther-
mal characteristics of the samples. The particle sizes of
the drugs were estimated using Marlven Zetasizer nano
ZS Particle size analyzer at the Department of Chemis-
try, University of Peradeniya, Sri Lanka.
Chemical analysis
Total cation concentration of the two drug samples were
determined both by the Inductively Coupled Plasma
Mass Spectrometer (ICPMS- Perkin Elmer Sciex ELAN-
6000) and Perkin Elmer-2800 Atomic Absorption
Spectrophotometer (AAS) after acid digestion [28] of the
inorganic portion of the drugs. The water soluble
portion of each drug sample was obtained by filtering
each aqueous suspension which was kept in a horizontal
shaker at room temperature for 5 h and then allowing
equilibrating for 19 h. Analyses of the solutions were
carried out on the AAS.
The instruments were calibrated using analytical grade
standard solutions of each element. The accuracy of the
analytical procedure was evaluated by analyzing reagent
blanks routinely with samples as well as by triplication
of sub-samples. Detection limits of different elements
vary from 1 to 0.001 mg/L for both ICP-MS and AAS.
Analyses were done at the Activation Laboratories Ltd.
Ontario, Canada and Department of Geology, University
of Peradeniya, Sri Lanka, respectively.
SEM analysis
Scanning Electron Microscopic (SEM- EVO - LS15)
analysis was carried out in order to determine the
bacteria-mineral interactions, morphological changes in
microbes and the characteristics of the drugs. Prior to
loading the samples for imaging, all the treated samples
and untreated bacterial samples (blank) were fixed with
formaldehyde for 2 h at room temperature, washed three
times with sterilized water and dehydrated twice with an
ethanol series, for 10 min at each concentration (30, 50,
70, 80, 90 and 100 %) [29, 30]. To minimize the artifacts
during imaging, all bacterial samples were observed
under the variable pressure mode. Analyses were done
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at the Department of Geology, University of Peradeniya,
Sri Lanka.
Results and discussion
Antimicrobial activity of AV and MR drugs and their
organic and inorganic components
In the present study, the in vitro antimicrobial activity of
six extracts (hexane, dichloromethane and methanol
extracts of two drugs) and four solid components (two
drugs and their residues) against five microbial strains,
and their antimicrobial activity were qualitatively and
quantitatively assessed by the presence or absence of
inhibition zones and by the number of colony forming
units (cfu). According to the results given in Fig. 1 and
Table 1, the extracts of the two drugs investigated
showed in vitro antimicrobial activities against some of
the bacterial strains tested, explained in detail as follows.
The antimicrobial sensitivity of a particular micro-
organism depended on the type of extract and the type
of assay (see Table 1). The hexane extract of AV showed
higher antibacterial activity than its dichloromethane
and methanol extracts, while the methanol extract of
MR exhibited higher antimicrobial activity than the hex-
ane and dichloromethane extracts. Among all tested ex-
tracts, the maximum antimicrobial activity was observed
with the methanol extract of MR against all the tested
strains when considering the clarity of inhibition and the
diameter of zone of inhibition. Diluted DMSO, used as
the negative control did not show any inhibition zone.
None of the extracts or solid components showed
antifungal activity against C. albicans with the diffusion
methods. Nevertheless, a slight reduction (one log re-
duction) in cfu was noticed in C. albicans broth cultures,
which were treated with MR drug (Table 1). However,
anticandidal activity of a similar drug product named
Hingula manikya rasa has been reported [9] at 8 mg/ml
concentration. This difference may be due to the
variable drug preparation techniques and conditions.
Further, different particle sizes of the drugs could have
an influence on the variable results.
According to the results of Miles and Misra
method, highest difference between the control cfu
and the corresponding treated broth sample was
observed for MR drug against S. aureus. Both drugs
and residues were active against all the bacterial spe-
cies when assessed with Miles and Misra method.
Antibacterial activity shown by inorganic residues of
both drugs with all the tested methods was consider-
able, indicating that mineral components also have a
high influence on antimicrobial activity in addition to
the plant extracts.
The broth dilutions were further examined by measur-
ing the turbidity of the microbial cultures using UV-
Visible spectrophotometer. The percentage reduction in
absorbance (when compared to the control) was com-
pared with the percentage inhibition of the microbial
species by Miles and Misra method (viable cell count)
(Fig. 2). According to the percentage reduction in ab-
sorbance MR drug had the highest antibacterial activity
(the greater the values of % reduction, the higher is the
activity), while the MR residue showed slightly higher
antimicrobial activity than AV residue against P.aerugi-
nosa, S.aureus and MRSA. Both drugs and their residues
did not show significant anticandidal activity. These re-
sults tallied with the cfu results obtained by the Miles
and Misra method (the grater the value of cfu, the lower
is the activity) (Fig. 2). However, in the broth dilution
assay the accuracy could be more if the contribution
made towards the absorbance values by the non-living
microbial cells could be eliminated, from broth culture.
Fig. 1 Well diffusion assay against S. aureus of (a) AV drug, residue and three extracts (b) MR drug, residue and three extracts (at 10,000 ppm
concentration) H - hexane, Di - dichloromethane, M- methanol, Dr- Drug, Re- inorganic residue of the drug, DMSO- negative control
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Table 1 Comparison of modified diffusion assay with viable cell count (cfu /ml) of broth cultures incorporated with the drug and residue of AV and MR (10,000 ppm)
Micro
organism
Arogyawardhana Vati (AV) Manikya Rasa (MR) Control
Modified diffusion assay Viable cell count (cfu) Modified diffusion assay Viable cell count (cfu)
Hexane Dichloro Methanol Drug Residue Drug Residue LogRcfu Hexane Dichloro Methanol Drug Residue Drug Residue LogRcfu
Drug Residue Drug Residue
P. aeruginosa + + + + + 52 × 109 17 × 108 9 10 vr vr + + + 5× 104 10 × 104 14 14 1018
E. coli + + − + vr 87 × 105 35 × 105 6 6 + + + + + 90 × 103 24 × 106 8 5 1011
S. aureus + + + + + 52 × 107 9 × 1013 14 8 + + + + + 63× 104 53 × 1012 17 9 1021
MRSA + vr vr + vr 77 × 108 15 × 1013 13 8 + + + + + 26 × 104 33× 1010 17 11 1021
C. albicans − − vr − − 15 × 106 14 × 106 0 0 − − − vr − 4 × 105 45 × 107 1 0 106



















Fig. 2 Antimicrobial effect of MR and AV drugs and residues by means of cfu and by means of percentage reduction in absorbance at
10,000 ppm concentration level against (a) P. aeruginosa (b) S. aureus (c) MRSA (d) E. coli and (e) C. albicans
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Mineralogical and chemical properties of drug samples
Mineralogical properties
XRD analyses show (Fig. 3) that the samples contain
characteristically different mineralogical constituents.
However, some common minerals such as cinnabar,
altered biotite and Fe-rich phases (magnetite, hematite)
were recorded from both samples (Table 2). Out of the
mineral constituents of drugs, pyrite, magnetite,
hematite, altered mica and other sulfide minerals are
effective against microbes [31].
Low peak intensities of the XRD patterns indicate
that the contents of cinnabar and arsenolite are rela-
tively low in the drugs. A number of metal-alloy and
amorphous phases are present (Fig. 3a, b). Since the
ingredient minerals used for the preparation of drugs
have been subjected to thermal treatments (up to
500 °C), these may be alteration products of some
minerals [9, 32]. Due to the inhomoginity of the sam-
ples and interferences (with crystalline and amorphos
phases) some of the peaks of minerals were hidden
during the rapid scanning of the samples. However,
the quality of the data was improved and the hidden
peaks of some of the minerals were identified by
slowing down the scan speed.
Based on the TGA data, the reduction in weight due
to the loss of moisture content, organic content and
volatile mineral constituents of MR was nearly ~70 % at
450 °C, while the corresponding value for AV drug was
84 % (see Fig. 4).
Although minerals with low boiling points (bp) such as
arsenolite (bp; 465 °C) and meta cinnabar (bp; 356 °C)
phases could be volatile by the temperature of 450 °C, all
the other identified minerals phases are thermally stable
in this temperature. Therefore, it could be concluded that
a higher fraction of the drugs consist of organic matter
while the amount of minerals present in the drugs are
relatively lower by weight, despite the antimicrobial
activity observed in inorganic residues.
Particle sizes of the MR and AV drugs ranged in
between 38–79 and 295–396 nm respectively (Fig. 5).
This indicates that both drug particles are small enough
to penetrate through the bacterial cell walls.
Major and trace elements
Table 3 represents the cation constituents of the total
digested and water soluble portion of AV and MR drugs.
Significantly higher concentrations of water soluble Na,
K, Ca, Mg and Fe cations were present in both drugs
and they can be considered as the available cations con-
tributing to the antimicrobial activity. Although heavy
metals such as Zn, Cu and As were present in significant
levels in totally acid digested samples, their water soluble
concentrations were below the detection limit of the in-
strument (AAS). In addition, both drugs contained rela-
tively lower amounts of Ag, Mn and Sn metal cations
(Table 3) which may contribute towards the antimicro-
bial activity with the interactions of microbes.
Fig. 3 X-ray diffraction spectra of (a) Arogyawardhana Vati (AV-1, AV-2) and (b) Manikya Rasa (MR1, MR2) drugs
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Probable mechanisms contributory to antimicrobial
activity
When considering the antibacterial activities of organic
and inorganic constituents of the drugs, it was evident
that organic and inorganic components contributed to
antimicrobial activity. Therefore, it could be inferred that
organic and inorganic components in these Rasashastra
preparations seem to be synergistically enhancing the
antibacterial properties of the drugs.
The growth rate of the microorganisms and membrane
permeability of the organism to the drug particles can
determine antimicrobial activity. Usually fast-growing
microbial species are said to have more susceptibility to
antibiotics than slow-growing microorganisms [4]. For
example, C. albicans, a fungus requires more time to
proliferate, and hence killing requires additional time
than the bacterial species [33]. At the same time drug
permeability through the fungal membranes are much
slower than the bacterial membranes. This could be an
explanation for the poor or no activity noticed against C.
albicans with the tested components, in the current
study.
Assay type based antimicrobial activity- contradictions
and suggestions
Evan though, the diameter of zone of inhibition in the
well diffusion assay and clarity of the zones in modified
diffusion assay were used to evaluate the antimicrobial
activity of the plant extracts with inorganic residues and
drugs (inorganic and organic components as a mixture),
it should be noted that the diffusion abilities are differ-
ent in components. As the different components have
different abilities to diffuse through the selected medium
these differences may contribute to the strength of
antimicrobial action of a particular extract. However in
this study, particular assays have been done only to
determine the contribution of each component (extracts,
drugs and residues) towards the antimicrobial activity.
In discussing the assays based on partially soluble solid
materials, it is recorded that broth dilution method is
Table 2 Summary of mineralogical constituents and organic and moisture content of drugs
AV Available ions as antimicrobial agents MR Available ions as antimicrobial agents
Mineral constituents Meta cinnabar S, Hg Metacinnabar Hg, S
Cinnabar Hg, S Arsenolite As
Arsenolite As Sphalerite Zn, S
Magnetite/ hematite Fe Chalcopyrite/ pyrite Cu, Fe, S
Biotite mica (altered) Fe, Mg, Al, Si Biotite mica (altered) Fe, Mg, Al, and Si
Volatile content (wt %) 84 % 70 %
Moisture content (wt %) 14 % 9.50 %
Fig. 4 TGA and DSC curves of (a) Arogyawardhana Vati (AV) and (b) Manikya Rasa (MR) drugs
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the best method to estimate the approximate potency of
a particular compound within a given period of time
under given pH values [34]. Therefore, the methodology
employed needs to be considered in more depth in
antimicrobial assays. From this point of view, further
investigations are required to improve the antimicrobial
methods for the partially soluble solid components and
plant extracts.
Physiochemical characteristics of the drugs
Several important physiochemical properties of the
mineral constituents of AV and MR drugs were
observed that could influence antibacterial activity
viz particle sizes, different shapes of particles which
are favorable for antimicrobial activity (Fig. 6a, b),
exchangeable and soluble elements and the mineral
phases (oxides, sulfides, silicates, metal alloys) of the
inorganic constituents.
Physical interaction with the microbial cell surface is a
most striking factor that contributes to the antimicrobial
activity of a particular particle. Small particles sizes have
a major influence against antimicrobial activity. Import-
ance of particle size of the drugs is evident when the
antibacterial activity of the drugs is compared with their
particle sizes. Both MR and AV drugs consisted of fine
particles. Further, MR drug with relatively smaller parti-
cles showed higher antibacterial activity than AV drug
with slightly larger particles. It has been observed that
antimicrobial activity increased with the decreasing par-
ticle size by many previous studies on metallic antibiotics
[35, 36]. Previous studies suggested that the enhanced
antimicrobial activity is due to the ease of interaction and
penetration of small particles (sizes ranging from 10 to
80 nm) into bacterial membranes [23]. Other than the
Fig. 5 Percentage number of particle sizes of AV and MR drugs in nanometers
Table 3 Cation constituents of totally digested AV and MR
drugs and the water soluble portion of AV and MR drugs
Analyte
symbol
Total (ppm) Water soluble (ppm)
AV AV MR
Mg 5800 4400 1600 3000
K 9100 6300 5600 5000
Ca 13300 3400 3500 1360
Fe 22400 28300 150 110
Na 870 1170 200 500
Al 4800 4100 − −
Ti 490 340 − −
S <1 90000 − −
P 980 820 − −
Cu >10000 >10000 ↑ ↑
As 12 >10000
Pb 84.7 351
Sr 68 25 bd bd
Zn 169 >10000
Cd 1.1 1.2
Cr 53 22 ↓ ↓
Co 3.5 3.6 − −
Li 4.4 5.3 − −
Rb 27.1 24.3 − −
Mn 237 89 − −
Sn 85.9 30.6 − −
Ni 29.2 15.5 − −
Sb 1.8 160 − −
Ba 180 7 − −
Ag 1.5 2 − −
bd below detection limit, − not measured note: data showing the total cation
detected from ICP-MS analysis and water-soluble cations detected by AAS
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particle size their shapes and surface charge that control
the release of metal ions from the drugs, play a role in
microbial toxicity [1]. Importances of the shapes of nano
drug particles as antimicrobial agents have been shown by
Pal et al., [37]. It is recorded that the highly reactive
triangular shaped nano-particles with antimicrobial activ-
ity compared to the rounded and rod shaped particles.
They have explained the differences in the observed trends
in inhibition with the shapes in terms of the percent active
faces present in nano-particles with different shapes.
Therefore, considering the shapes of AV and MR drug
particles, MR drug could be more reactive than AV as MR
consisted of differently shaped particles in comparison to
AV (Fig. 6a, b). In addition, as observed in the current
research, all bacterial species showed inhibition zones with
AV and MR residues, when directly placed over the micro-
organisms in the modified diffusion assay. It could be sug-
gested that antibacterial action of inorganic residues may
have been induced due to the effective physical nature of
the processed mineral particles.
In addition to inheritent antimicrobial properties of
inorganic residues, the organic constituents may have
promoted the antimicrobial action of mineral constitu-
ents by increasing the release of the antimicrobial metal
cations in to the growth medium. Since, most of the
antimicrobial plant constituents possess slightly acidic
pH values (around pH 5), the releasing capacity of meta-
lic constituents could be enhance by the organic matter
in drug mixtures. Further, acidic medium provided by
the organic constituents could enhance the cell mem-
brane permeability of the bacteria [38]. Therefore, metal-
lic constituents can easily reach the targeted bacterial
sites. In addition to the action of pH, plant constituents
could contribute to the number of antibacterial mecha-
nisms leading to microbial lethality. However, the action
of organic constituents of the drugs cannot be elabo-
rated here due to the complexity of the combinations of
organic matter.
Evaluating antibacterial process / possible mechanisms
Significant alterations in treated bacterial samples were
observed by SEM. The electron micrographs of treated
bacteria (S. aureus and E. coli) samples are shown in
Fig. 7. In a view of Fig. 7b shrinked cells of S. aureus can
be seen attached to the surface of AV drug particles, S.
aureus treated with MR drug showed (Fig. 7c) relatively
higher damage to cells compared to the AV treated
S.aureus. Similarly, MR treated E.coli (Fig. 7f ) showed a
stronger growth inhibition compared to the AV treated
E.coli (Fig. 7e). These SEM observations tally with the
results obtained from the antimicrobial assays which
showed higher inhibition effect of MR drug compared to
the AV drug. Altered microbes with both drugs had
either relatively flattened and elongated or shorter and
more compact shapes compared to their untreated
bacterial controls (Fig. 7a and d). F). Shortening of the
bacterial cells (Fig. 7b) indicates that treated bacteria
was not able to grow to maximum length; whereas
expansion and elongation of the cells (Fig. 7e) could be a
result of accumulation of drug particles inside the cell
wall or extra hydration of the bacterial cells.
Antibacterial activity of AV and MR could be directly
related to the actions of their metal oxide, pyrite, mica,
cinnabar and other sulfide mineral phases. Although
antimicrobial mechanism should be considered in
combination, possible effect of most influential minerals
are discussed individually based on literature (Table 4).
In addition to the contribution of the well-known anti-
bacterial constituents described in Table. 4, processed mica
(Abhrak bhasma) individually possesses antibacterial activ-
ity against S. aureus and MRSA in the aqueous medium
[39]. Therefore, the water soluble cations in mica might
have contributed to the antibacterial activity rather than its
solid constituents [40, 41]. Further, surface charges of min-
erals can interact with bacteria [42, 43]. Bacteria (negatively
charged) can be easily attracted to the mineral surfaces with
positive charges by the electrostatic interaction. Therefore,
Fig. 6 SEM images of (a) AV drug rich in rounded shaped aggregates of nano-size particles and randomly distributed elongated grains of minerals
(b) MR drug consisting of aggregates of acicular, triangular, rounded and irregular shaped nano-size particles rich in metal sulfides
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minerals present in the oxidized form in the drugs (iron ox-
ides and other metal oxides) could contribute to damage
the bacterial cell wall and increases permeability to other
materials.
Overall, it can be suggested that the growth inhibition
and cellular death of microorganisms are a result of a com-
bination of different mechanisms. Further, depending on
the chemistry of the minerals/metals, the mechanisms of
antimicrobial activity may differ in the two drugs assessed.
Effect of toxic metals
Metal concentrations were determined only for the inor-
ganic residues in the current study. For 1 g of each drug,
the mineral constituents were <0.16 and <0.3 g for AV
and MR respectively. Therefore the oral dosage of these
drugs used in the current study could have lower metal
toxicity than the observed values with cation analysis.
Kumar et al., [13], have carried out safety evaluation of
Arogyavardhini vati (AV) on brain, liver and kidney in
rats using different oral doses of 50, 250 and 500 mg/kg
Table 4 Possible antimicrobial mechanisms of minerals in MR
and AV drugs
Mineral Mechanism of action
Pyrite/
chalcopyrite
Spontaneously generate hydrogen peroxide
(H2O2) and hydroxyl radicals when they are
placed in water. Caused to degrade ribosomal




Could interact with the oxygen radicals in the
drug-microbe aqueous mixture which may in
turn be transformed into pentathionic acid
(H2S5O6), which could be a source of the
antibacterial activity of water based broth
preparations [46, 47].
Oxides (zinc,
copper and iron oxides)
Could act as sources that create hydrogen
peroxide oxide radicals which contribute to
the inhibition of both gram positive and
negative bacterial species [48].
Fig. 7 SEM images of (a) cocci shaped cells of untreated S. aureus with smooth, intact surfaces. b altered S. aureus cells after treating with
AVdrug (c) highly altered S. aureus cells after treating with MR drug (d) bacilli shaped cells of untreated E. coli (e) altered E. coli with cracked and
damaged bacterial cell wall after treating with AV drug (f) completely destroyed E. coli cells after treating with MR drug
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(one, five and ten times of human equivalent dose
respectively) and there results have revealed that AV in
the doses equivalent up to ten times of the human dose
administered to rats for 28 days does not have appre-
ciable toxicological effects on brain, liver and kidney.
Further their studies on safety of AV (500 mg) treatment
[44] for dyslipidemia patients (87) by assessing hepatic
function (aminotransferase [ALT], aspartate transamin-
ase [AST], alkaline phosphatase [ALP], bilirubin, and β2
microglobulin), renal function (urea and creatinine and
NGAL) tests, and urine mercury level have shown that
there is no significant change in serum ALT, AST, ALP
and bilirubin, urea, creatinine β2 microglobulin, and
NGAL levels at the end of study as compared to the
baseline levels. Therefore, they have concluded that AV
treatment is safe and effective for dyslipidemia.
In addition, previous investigations carried out on the
genotoxic potential of Manikya Rasa (MR) (2000 mg/kg), in
Wistar rats by Micronucleus assay and Comet assay re-
vealed the lack of induction of micronuclei or DNA damage
despite the presence of traces of transformed toxic heavy
metals in these formulations [45, 46].
Although, there are many supportive studies recorded
on the minimal cytotoxicity of the AV and MR drugs it
is necessary to remove or replace the toxic cations in the
drugs such as Cu, As, Zn, Pb, Sn and Hg (Table 4) by
antibacterial cations which are free of adverse effects in
the oral applications. In addition, toxicity of the drugs
can be minimized by reducing the effective dose of the
drugs with the improvement of the pharmaceutical qual-
ities such as high specific surface area (by increasing the
fine fraction of the particles) and solubility. Further, care
should be taken to select the raw materials with minimal
toxic substances. Oral use of these drugs without the
knowledge of their composition could be harmful [5].
Therefore, these drugs should be tested for the threshold
values of cationic constituents prior to the applications.
Conclusions
AV and MR drugs have antibacterial potential against
tested gram positive (Staphylococcus aureus and MRSA)
and gram negative (Pseudomonas aeruginosa, Escheri-
chia coli) bacterial species. Our analyses suggest that
mineral and herbal constituents in the AV and MR Rasa-
shastra drugs contribute to the antibacterial activity.
Therefore, AV and MR Rasashastra preparations could
provide alternative treatments to synthetic antibiotics
against human bacterial infections. AV and MR drugs
possess a number of physical and chemical characteris-
tics, such as small particle sizes and higher water solubil-
ity which contribute to enhance the antimicrobial
mechanisms.
Even though these traditional herbo-metallic prepara-
tions seem to hold great promise for their antimicrobial
efficacy, further biochemical and toxicological studies
are needed for a greater understanding of their toxicity
to humans.
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